Drug recall · January 24, 2018
Lovastatin Tablets USP recall
Why: Failed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lovastatin Tablets USP, 40 mg, 50 Tablets (5x10) Unit Dose carton, Rx only, Manufactured for AvKARE, Inc. Pulaski, TN 38478, NDC 50268-512-15.
- Lots / codes
Lot: 15270, Exp. 01/18
- Quantity
- 237 cartons
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide in the USA
- Initiated
- January 3, 2018 · Voluntary: Firm initiated
- Classified
- January 12, 2018
- Reported
- January 24, 2018
- Ended
- May 8, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lovastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.